SKB Biopharma Avails of 300 Million Yuan Structured Deposits From China's Industrial Bank

MT NewswiresDec 18 01:04 ET

SKB BIO-B (06990) subscribed to a total of 0.3 billion yuan in structured deposits from Industrial Bank.

SKB BIO-B (06990) announced that on December 17, 2024, the company signed with Industrial Bank...

Zhitong FinanceDec 17 10:00 ET

Express News | Sichuan Kelun-Biotech Biopharmaceutical - to Subscribe 2 Structured Deposits From Industrial Bank of RMB170 Mln and RMB130 Mln

ReutersDec 17 09:57 ET

Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.

The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.

Zhitong FinanceDec 16 01:21 ET

Sinolink: The warm breeze of medical policies arrives first, focusing on the sectors of innovative drugs and generic innovative drugs with high investment opportunities.

In 2024, the pharmaceutical sector continues to face pressure and is searching for a bottom, but long-term demand remains stable, and there are reversal trends in policies, funding, and fundamentals, which is expected to yield excess returns in the pharmaceutical field in 2025.

Zhitong FinanceDec 9 03:14 ET

Guosen's 2025 strategy for csi sws health care index: Innovation leads to industrial upgrade.

Current domestic medical demand continues to upgrade, the macro economy is expected to gradually warm up, and under geopolitical disturbances, the country is likely to increase support for self-controllable initiatives.

Zhitong FinanceDec 9 01:47 ET